Efficacy and safety of repeated infusion of levosimendan in outpatients with advanced heart failure: a real-world experience

J Cardiovasc Med (Hagerstown). 2020 Nov;21(11):919-921. doi: 10.2459/JCM.0000000000000983.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Ambulatory Care*
  • Cardiovascular Agents / administration & dosage*
  • Cardiovascular Agents / adverse effects
  • Exercise Tolerance / drug effects
  • Female
  • Functional Status
  • Heart Failure, Systolic / diagnosis
  • Heart Failure, Systolic / drug therapy*
  • Heart Failure, Systolic / physiopathology
  • Hospitalization
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Recovery of Function
  • Simendan / administration & dosage*
  • Simendan / adverse effects
  • Stroke Volume / drug effects
  • Time Factors
  • Treatment Outcome
  • Ventricular Function, Left / drug effects

Substances

  • Cardiovascular Agents
  • Simendan